{"id":42593,"date":"2015-02-13T00:00:00","date_gmt":"2015-02-12T23:00:00","guid":{"rendered":"https:\/\/techma.bakertilly.es\/necesita-concentrarse-el-sector-biotecnologico-en-espana\/"},"modified":"2025-03-12T11:25:55","modified_gmt":"2025-03-12T10:25:55","slug":"necesita-concentrarse-el-sector-biotecnologico-en-espana","status":"publish","type":"post","link":"https:\/\/techma.bakertilly.es\/en\/necesita-concentrarse-el-sector-biotecnologico-en-espana\/","title":{"rendered":"Does the biotech sector in Spain need to concentrate?"},"content":{"rendered":"
2014 has been a good year for the biotechnology sector in Spain, mainly due to the improvement in public-private collaboration that is being consolidated in the sector. A number of projects have been carried out mergers and acquisitions<\/a> and M&A transactions<\/a> and new venture capital funds focused on biotechnology have emerged.<\/span><\/address>\n

<\/p>\n

 <\/p>\n

Spanish biotechnology moves towards concentration<\/strong><\/span><\/p>\n

One of the challenges facing the Spanish biotechnology sector is to tackle its atomisation and reach a critical dimension for its growth, mainly international. There are currently around 600 companies, most of them small and medium-sized, whose main activity is biotechnology, which makes their visibility very difficult.<\/span><\/p>\n

While it is true that 2014 has seen a number of projects in the mergers and acquisitions<\/a> precisely for this purpose, such as the purchase of the Basque \u00a0Biophenix<\/a>,<\/span> which develops drug screening by Bionaturis,<\/span> developing biologic medicines, the acquisition of Kiro-Robotics<\/span> by the giant Grifols <\/a><\/span>or the purchase you have made Natraceutical<\/a><\/span> of the laboratory Reig Jofre<\/span><\/span>a French laboratory with a presence in Europe and the USA. In addition, in 2015 it has also announced the purchase of the French company Trophos<\/span> 120m from Roche, to which a further \u20ac350m could be added depending on milestones. Trophos has a proprietary molecule, TRO19622, which is being investigated in patients with spinal muscular atrophy (SMA),\u00a0<\/span><\/p>\n

BioSpain<\/span>\u00a02014 was an important forum for doing business, with more than 200 exhibitors and 50 investors, 80 percent of them international.<\/span><\/p>\n

\"The pharmaceutical sector is moving towards the consolidation of a map made up of fewer and larger laboratories\", says Diego Guti\u00e9rrez, partner at Abra-Invest.<\/a><\/span><\/span><\/p>\n

Other challenges for 2015<\/strong><\/span><\/p>\n

Among the challenges for 2015 are the need for international investors in Spanish companies, which will allow us to compete with the big companies on a global level. This year international investments have already been made in Spain, such as the \u20ac3M investment of the Japanese multinational Yamada BeeFarm <\/a><\/span>3 in the Spanish company Life Length.\u00a0<\/span><\/span><\/span><\/p>\n

Another challenge is to alleviate public indebtedness in the biotech sector and to take measures to support SMEs to overcome the crisis.<\/span><\/p>\n

\u00a0Other posts that may interest you<\/span><\/strong><\/p>\n

New developments in biotech funds in Spain (En-2015)<\/a><\/span><\/p>\n

Juan Diego Cuenca, partner of Abra-invest, analyses the biotechnology sector on Gestionaradio <\/a><\/span><\/p>\n

M&A deals in biotech companies in Spain are on the rise<\/a><\/span><\/p>","protected":false},"excerpt":{"rendered":"

2014 has been a good year for the biotech sector in Spain, mainly due to the improvement in public-private collaboration that is being consolidated in the sector. Several acquisitions and mergers have taken place and new venture capital funds focused on biotechnology have appeared.<\/p>","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_acf_changed":false,"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":""},"categories":[2277],"tags":[250],"sectores":[],"tipo-contenido":[2260],"class_list":["post-42593","post","type-post","status-publish","format-standard","hentry","category-multiplos-de-empresas-cotizadas","tag-biotecnologia-en-espana","tipo-contenido-noticias"],"acf":[],"_links":{"self":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/42593","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/comments?post=42593"}],"version-history":[{"count":0,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/posts\/42593\/revisions"}],"wp:attachment":[{"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/media?parent=42593"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/categories?post=42593"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tags?post=42593"},{"taxonomy":"sectores","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/sectores?post=42593"},{"taxonomy":"tipo-contenido","embeddable":true,"href":"https:\/\/techma.bakertilly.es\/en\/wp-json\/wp\/v2\/tipo-contenido?post=42593"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}